Advances in Hematological Malignancies
Recent years have witnessed remarkable progress in the area of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative approaches, offering promise for more effective treatment optio